AEON Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.16	5.16	9.75	5.13	0
Cash & Cash Equivalents	5.16	5.16	9.75	5.13	0
Cash Growth	-47.08%	-47.08%	90.05%	-	-
Other Current Assets	1.06	1.06	0.09	0.03	0
Total Current Assets	6.22	6.22	9.84	5.15	0
Property, Plant & Equipment	0.59	0.59	0.91	0.92	0
Other Long-Term Assets	0.03	0.03	0.03	0.36	0.08
Total Long-Term Assets	0.62	0.62	0.94	1.28	0.08
Total Assets	6.85	6.85	10.78	6.44	0.08
Accounts Payable	3.39	3.39	7.81	1.19	0.02
Current Debt	0	0	70.87	15.6	0.04
Other Current Liabilities	9.66	9.66	3.9	4.01	0
Total Current Liabilities	13.05	13.05	82.57	20.8	0.06
Long-Term Debt	0	0	60.67	71.29	0
Other Long-Term Liabilities	146.84	146.84	0	0.22	0
Total Long-Term Liabilities	146.84	146.84	60.67	71.51	0
Total Liabilities	159.89	159.89	143.24	92.31	0.06
Total Debt	0	0	131.53	86.89	0.04
Debt Growth	-	-	51.38%	225071.04%	-
Retained Earnings	-473.6	-473.6	-474.84	-422.28	-0
Shareholders' Equity	-153.04	-153.04	-287.5	-234.94	0.02
Net Cash / Debt	5.16	5.16	-121.79	-81.76	-0.04
Net Cash Per Share	0.14	0.14	-0.88	-0.65	-0.01
Working Capital	-6.83	-6.83	-72.74	-15.65	-0.06
Book Value Per Share	-4.12	-4.12	-2.07	-1.86	0.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).